Endo Pharmaceuticals Inc., Jubilant Organosys deal

Jubilant's Jubilant Biosys Ltd. subsidiary will provide drug discovery and development services for Endo, which will own the resulting compounds. The three-year deal will focus initially on cancer. Ju...